Pharmaceutical

Ahead of New York Fashion Week, Gilead Sciences is strutting its marketing stuff to raise awareness of primary biliary cholangitis (PBC). The pharma—w...

This compelling four-part podcast series, “The Progress Profile: Alzheimer’s Research in Focus,” brings together world-renowned experts to explore the...

Despite persistent uncertainty under the Trump administration’s international trade policy, Korea’s Samsung Biologics continues to snare billion-dolla...

Endo is ramping up the next phase of its Dupuytren's contracture marketing drive. Not long after running its first branded ad for Xiaflex in the indic...

Regeneron and Sandoz have reached a settlement that resolves all patent litigation related to the Swiss company’s biosimilar version of eye disease dr...

Amid a yearslong wave of enthusiasm and uptake for Eli Lilly and Novo Nordisk's blockbuster obesity medicines, the drugs have scored a strong endorsem...

Private equity company Permira is looking to offload its CDMO Cambrex in a sale that could value the latter company at up to $4 billion, according to...

Lundbeck is making a big push on the company’s capital reallocation initiative, handing over its operations in 27 markets to partners. Lundbeck will t...

Jamie-Lynn Sigler shot to stardom at the turn of the millennium in her role as Meadow Soprano, daughter of mob boss Tony, on “The Sopranos.” During th...

Dive Brief: Novartis on Tuesday said it will pay $1.4 billion to acquire the New York-based biotechnology company Tourmaline Bio and its experimental...